Search Results - "Truma, A."

OC 26.3 Main Features of Ischemic Stroke in Patients with Acute Immune-Mediated Thrombotic Thrombocytopenic Purpura by Truma, A., Agosti, P., Artoni, A., Galli, N., Giannotta, J., De Leo, P., Ferrari, B., Mancini, I., Peyvandi, F.

Get full text

PB0500 Edoxaban for Acute and Long-Term Treatment of Venous Thromboembolism: Real-Life Data from a Single Center Cohort Study by Abbattista, M., Capecchi, M., Barbullushi, K., Cassanello, G., Truma, A., Gianniello, F., Artoni, A., Scimeca, B., Bucciarelli, P., Peyvandi, F.

Get full text

OC 42.2 Incidence and Risk Factors of Major Adverse Cardiovascular Events in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura during Remission by Agosti, P., Boggio, F., De Leo, P., Truma, A., Giannotta, J., Artoni, A., Ferrari, B., Mancini, I., Peyvandi, F.

Get full text

PB1239 Prophylaxis with Extended Half-life Products in Patients with Hemophilia A: Real-life Data of the Milan Cohort by Ciavarella, A., Truma, A., Ballardini, F., Abbattista, M., Arcudi, S., Gualtierotti, R., Mistretta, C., Nicolò, G., Novembrino, C., Siboni, S., Peyvandi, F.

Get full text

OC 60.4 Joint Damage in Patients Affected by Von Willebrand Disease: A Single-Center Experience by Gualtierotti, R., Arcudi, S., Giachi, A., Smania, M., Truma, A., Ciavarella, A., Begnozzi, V., Boccalandro, E., Biguzzi, E., Siboni, S., Peyvandi, F.

Get full text

PB0316 Bortezomib for the Treatment of Multi-Refractory Immune-Mediated Thrombotic Thrombocytopenic Purpura: An Italian Multicenter Survey by Giannotta, J., Artoni, A., Mancini, I., Truma, A., Agosti, P., Carpenedo, M., Mancini, G., Molteni, A., Rinaldi, E., Bocchia, M., Napolitano, M., Prezioso, L., Cuccaro, A., Scarpa, E., Grimaldi, D., Massaia, M., Peyvandi, F.

Get full text